These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 24022868)
1. Dehydroepiandrosterone exerts antiglucocorticoid action on human preadipocyte proliferation, differentiation, and glucose uptake. McNelis JC; Manolopoulos KN; Gathercole LL; Bujalska IJ; Stewart PM; Tomlinson JW; Arlt W Am J Physiol Endocrinol Metab; 2013 Nov; 305(9):E1134-44. PubMed ID: 24022868 [TBL] [Abstract][Full Text] [Related]
2. Alternative mechanism for anti-obesity effect of dehydroepiandrosterone: possible contribution of 11β-hydroxysteroid dehydrogenase type 1 inhibition in rodent adipose tissue. Tagawa N; Minamitani E; Yamaguchi Y; Kobayashi Y Steroids; 2011 Dec; 76(14):1546-53. PubMed ID: 21945397 [TBL] [Abstract][Full Text] [Related]
3. Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue. Apostolova G; Schweizer RA; Balazs Z; Kostadinova RM; Odermatt A Am J Physiol Endocrinol Metab; 2005 May; 288(5):E957-64. PubMed ID: 15613680 [TBL] [Abstract][Full Text] [Related]
4. A novel selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis. Bujalska IJ; Gathercole LL; Tomlinson JW; Darimont C; Ermolieff J; Fanjul AN; Rejto PA; Stewart PM J Endocrinol; 2008 May; 197(2):297-307. PubMed ID: 18434359 [TBL] [Abstract][Full Text] [Related]
5. The role of 11beta-hydroxysteroid dehydrogenase 1 in adipogenesis in thyroid-associated ophthalmopathy. Tomlinson JW; Durrani OM; Bujalska IJ; Gathercole LL; Tomlins PJ; Reuser TT; Rose GE; Curnow SJ; Stewart PM; Walker EA; Rauz S J Clin Endocrinol Metab; 2010 Jan; 95(1):398-406. PubMed ID: 19880789 [TBL] [Abstract][Full Text] [Related]
6. Insulin and dexamethasone dynamically regulate adipocyte 11beta-hydroxysteroid dehydrogenase type 1. Balachandran A; Guan H; Sellan M; van Uum S; Yang K Endocrinology; 2008 Aug; 149(8):4069-79. PubMed ID: 18467433 [TBL] [Abstract][Full Text] [Related]
7. Dehydroepiandrosterone 7alpha-hydroxylation in human tissues: possible interference with type 1 11beta-hydroxysteroid dehydrogenase-mediated processes. Hennebert O; Chalbot S; Alran S; Morfin R J Steroid Biochem Mol Biol; 2007 May; 104(3-5):326-33. PubMed ID: 17467270 [TBL] [Abstract][Full Text] [Related]
8. Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity. Tomlinson JW; Sinha B; Bujalska I; Hewison M; Stewart PM J Clin Endocrinol Metab; 2002 Dec; 87(12):5630-5. PubMed ID: 12466364 [TBL] [Abstract][Full Text] [Related]
9. Dehydroepiandrosterone (DHEA) treatment in vitro inhibits adipogenesis in human omental but not subcutaneous adipose tissue. Rice SP; Zhang L; Grennan-Jones F; Agarwal N; Lewis MD; Rees DA; Ludgate M Mol Cell Endocrinol; 2010 May; 320(1-2):51-7. PubMed ID: 20176080 [TBL] [Abstract][Full Text] [Related]
10. 11Beta-hydroxysteroid dehydrogenase type 1 in differentiating omental human preadipocytes: from de-activation to generation of cortisol. Bujalska IJ; Walker EA; Tomlinson JW; Hewison M; Stewart PM Endocr Res; 2002 Nov; 28(4):449-61. PubMed ID: 12530648 [TBL] [Abstract][Full Text] [Related]
11. Inter-conversion of 7alpha- and 7beta-hydroxy-dehydroepiandrosterone by the human 11beta-hydroxysteroid dehydrogenase type 1. Muller C; Pompon D; Urban P; Morfin R J Steroid Biochem Mol Biol; 2006 Jun; 99(4-5):215-22. PubMed ID: 16603347 [TBL] [Abstract][Full Text] [Related]
12. Preadipocyte 11beta-hydroxysteroid dehydrogenase type 1 is a keto-reductase and contributes to diet-induced visceral obesity in vivo. De Sousa Peixoto RA; Turban S; Battle JH; Chapman KE; Seckl JR; Morton NM Endocrinology; 2008 Apr; 149(4):1861-8. PubMed ID: 18174284 [TBL] [Abstract][Full Text] [Related]
13. Differential modulation of 3T3-L1 adipogenesis mediated by 11beta-hydroxysteroid dehydrogenase-1 levels. Kim J; Temple KA; Jones SA; Meredith KN; Basko JL; Brady MJ J Biol Chem; 2007 Apr; 282(15):11038-46. PubMed ID: 17311922 [TBL] [Abstract][Full Text] [Related]
14. 7α-hydroxylation of dehydroepiandrosterone does not interfere with the activation of glucocorticoids by 11β-hydroxysteroid dehydrogenase in E(t)C cerebellar neurons. Gottfried-Blackmore A; Jellinck PH; Vecchiarelli HA; Masheeb Z; Kaufmann M; McEwen BS; Bulloch K J Steroid Biochem Mol Biol; 2013 Nov; 138():290-7. PubMed ID: 23851218 [TBL] [Abstract][Full Text] [Related]
15. Emodin, an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, regulates adipocyte function in vitro and exerts anti-diabetic effect in ob/ob mice. Wang YJ; Huang SL; Feng Y; Ning MM; Leng Y Acta Pharmacol Sin; 2012 Sep; 33(9):1195-203. PubMed ID: 22922341 [TBL] [Abstract][Full Text] [Related]
16. Growth hormone (GH) or insulin-like growth factor (IGF)-I represses 11beta-hydroxysteroid dehydrogenase type 1 (HSD1) mRNA expression in 3T3-L1 cells and its activity in their homogenates. Morita J; Hakuno F; Hizuka N; Takahashi S; Takano K Endocr J; 2009; 56(4):561-70. PubMed ID: 19352050 [TBL] [Abstract][Full Text] [Related]
17. 17Beta-estradiol inhibits 11beta-hydroxysteroid dehydrogenase type 1 activity in rodent adipocytes. Tagawa N; Yuda R; Kubota S; Wakabayashi M; Yamaguchi Y; Kiyonaga D; Mori N; Minamitani E; Masuzaki H; Kobayashi Y J Endocrinol; 2009 Jul; 202(1):131-9. PubMed ID: 19380458 [TBL] [Abstract][Full Text] [Related]
18. Role of 11-beta-hydroxysteroid dehydrogenase type 1 in differentiation of 3T3-L1 cells and in rats with diet-induced obesity. Liu Y; Sun WL; Sun Y; Hu G; Ding GX Acta Pharmacol Sin; 2006 May; 27(5):588-96. PubMed ID: 16626514 [TBL] [Abstract][Full Text] [Related]
19. Dehydroepiandrosterone reduces proliferation and differentiation of 3T3-L1 preadipocytes. Lea-Currie YR; Wen P; McIntosh MK Biochem Biophys Res Commun; 1998 Jul; 248(3):497-504. PubMed ID: 9703954 [TBL] [Abstract][Full Text] [Related]
20. Structural homology between 11 beta-hydroxysteroid dehydrogenase and Hernández-Bustamante I; Santander-Plantamura Y; Mata-Espinosa D; Reyes-Chaparro A; Bini EI; Torre-Villalvazo I; Tovar AR; Barrios-Payan J; Marquina-Castillo B; Hernández-Pando R; Carranza A Front Endocrinol (Lausanne); 2022; 13():1055430. PubMed ID: 36699022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]